MIIG® 115 Minimally-Invasive Injectable Graft

Injects. Hardens. Replaced By Bone. MIIG® Injectable Graft has been developed for less invasive fracture treatment in contained metaphyseal defects with open or closed reduction. The injectable graft hardens inside the body, provides temporary intraoperative stabilization, and is receptive to adjunctive hardware. OSTEOSET® Surgical-Grade Calcium Sulfate has demonstrated clinical efficacy as an osteoconductive biomaterial. Wright Medical's proprietary alpha crystal technology reliably produces a bone graft that performs particularly well in contained, metaphyseal defects such as those in the tibial plateau, distal radius or in pilon fracture.

MIIG® 115 Graft Design Features

• Injects through small gauge needle
• Hardens in defect
• May be drilled to accommodate hardware placement
• Provides temporary intraoperative fracture stabilization
• Completely resorbs
• Regenerates bone
• Ideal for metaphyseal defects

*Minimally Invasive Injectable Graft is not a substitute for rigid internal or external fixation.

	Case Studies
	Document Title: MIIG®: An Injectable Solution For Complex Tibia Plateau Fractures - SK933-1002 Click Here to Download PDF Document Title: MIIG®: Technique and Clinical Results Using Injectable Calcium Sulfate for Intraoperative Stabilization and Grafting: A Case Report of Two Tibia Plateau Fractures - SK953-1102 Click Here to Download PDF Document Title: miniMIIG®: Closed Treatment Option For Managing Distal Radius Fractures - SK810-602-REV.10-02 Click Here to Download PDF

	Patent

	Product Brochures
	MIIG® 115 Minimally-Invasive Injectable Graft - Technical Monograph - SK691-102
	Click Here to Download PDF
	Advanced Grafting Solutions Brochure SK689-902 R6.02.pdf
	Click Here to Download PDF